AU2002217227A1 - 2-butyl-3-(4-(3(dibutylamino)propoxy)benzoyl)-5-nitro- benzofuran hydrochloride and preparation thereof - Google Patents

2-butyl-3-(4-(3(dibutylamino)propoxy)benzoyl)-5-nitro- benzofuran hydrochloride and preparation thereof

Info

Publication number
AU2002217227A1
AU2002217227A1 AU2002217227A AU1722702A AU2002217227A1 AU 2002217227 A1 AU2002217227 A1 AU 2002217227A1 AU 2002217227 A AU2002217227 A AU 2002217227A AU 1722702 A AU1722702 A AU 1722702A AU 2002217227 A1 AU2002217227 A1 AU 2002217227A1
Authority
AU
Australia
Prior art keywords
dibutylamino
propoxy
benzoyl
nitro
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217227A
Inventor
Michel Biard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU2002217227A1 publication Critical patent/AU2002217227A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/22Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002217227A 2000-12-11 2001-12-10 2-butyl-3-(4-(3(dibutylamino)propoxy)benzoyl)-5-nitro- benzofuran hydrochloride and preparation thereof Abandoned AU2002217227A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0016069 2000-12-11
FR0016069A FR2817865B1 (en) 2000-12-11 2000-12-11 AMINOALKOXYBENZOYLE DERIVATIVE IN SALT FORM, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF AS SYNTHESIS INTERMEDIATE
PCT/FR2001/003900 WO2002048078A1 (en) 2000-12-11 2001-12-10 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof

Publications (1)

Publication Number Publication Date
AU2002217227A1 true AU2002217227A1 (en) 2002-06-24

Family

ID=8857481

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217227A Abandoned AU2002217227A1 (en) 2000-12-11 2001-12-10 2-butyl-3-(4-(3(dibutylamino)propoxy)benzoyl)-5-nitro- benzofuran hydrochloride and preparation thereof

Country Status (21)

Country Link
US (1) US6846936B2 (en)
EP (1) EP1351907B1 (en)
JP (2) JP4437004B2 (en)
CN (2) CN1295200C (en)
AR (1) AR035663A1 (en)
AT (1) ATE345319T1 (en)
AU (1) AU2002217227A1 (en)
BR (1) BR0116065B1 (en)
CA (1) CA2429268C (en)
CZ (1) CZ303489B6 (en)
DE (1) DE60124587T2 (en)
DK (1) DK1351907T3 (en)
ES (1) ES2276741T3 (en)
FR (1) FR2817865B1 (en)
HK (1) HK1055944A1 (en)
HR (1) HRP20030471B1 (en)
HU (1) HUP0500981A3 (en)
MX (1) MXPA03005223A (en)
PL (1) PL206029B1 (en)
SK (1) SK287770B6 (en)
WO (1) WO2002048078A1 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356054B (en) 2004-03-31 2012-01-11 Activus Pharma Co Ltd Quaternary ammonium compound, producing method the
GB0719180D0 (en) * 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
FR2930149B1 (en) * 2008-04-17 2011-02-18 Sanofi Aventis ASSOCIATION OF DRONEDARONE WITH AT LEAST ONE DIURETIC, ITS THERAPEUTIC APPLICATION
KR20100135909A (en) * 2008-04-17 2010-12-27 사노피-아벤티스 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
EP2246341A1 (en) 2009-01-23 2010-11-03 Lonza Ltd. Process for preparing 2-Alkyl-3-aroyl-5-nitro-benzofurans
JP5788381B2 (en) * 2009-04-08 2015-09-30 カンブレックス カルルスクーガ アクチ ボラケットCambrex Karlskoga Ab A novel process for preparing hydroxylamine and drugs
UY32656A (en) 2009-05-27 2010-12-31 Sanofi Aventis PROCEDURE TO PRODUCE BENZOFURANS
UY32657A (en) 2009-05-27 2010-12-31 Sanofi Aventis PROCEDURE FOR THE MANUFACTURE OF DRONEDARONA INTERMEDIATE PRODUCTS
CN101993427B (en) * 2009-08-26 2012-10-10 成都伊诺达博医药科技有限公司 New method for preparing Dronedarone
HUP0900759A2 (en) 2009-12-08 2011-11-28 Sanofi Aventis Novel process for producing dronedarone
HUP1000010A2 (en) 2010-01-08 2011-11-28 Sanofi Sa Process for producing dronedarone
IT1398317B1 (en) * 2010-02-23 2013-02-22 Chimico Internaz Spa Lab NEW PROCEDURE FOR DRONEDARONE PREPARATION.
FR2957079B1 (en) 2010-03-02 2012-07-27 Sanofi Aventis PROCESS FOR THE SYNTHESIS OF CETOBENZOFURAN DERIVATIVES
EP2371824A1 (en) * 2010-03-08 2011-10-05 Ratiopharm GmbH Crystalline dronedarone salts
FR2958290B1 (en) 2010-03-30 2012-10-19 Sanofi Aventis PROCESS FOR THE PREPARATION OF SULFONAMIDO-BENZOFURAN DERIVATIVES
FR2958291B1 (en) 2010-04-01 2013-07-05 Sanofi Aventis PROCESS FOR PREPARING AMINO-BENZOFURAN DERIVATIVES
HUP1000330A2 (en) * 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2012004658A2 (en) 2010-07-09 2012-01-12 Frichem Private Limited Process for preparation of n-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide, acid addition salts and product thereof
WO2012007959A1 (en) * 2010-07-16 2012-01-19 Glenmark Generics Limited Process for preparing dronedarone
FR2962731B1 (en) 2010-07-19 2012-08-17 Sanofi Aventis PROCESS FOR THE PREPARATION OF AMINO-BENZOYL-BENZOFURAN DERIVATIVES
FR2963006B1 (en) 2010-07-21 2013-03-15 Sanofi Aventis PROCESS FOR THE PREPARATION OF NITRO-BENZOFURAN DERIVATIVES
HUP1000386A2 (en) 2010-07-22 2012-05-29 Sanofi Sa Novel process for producing dronedarone
WO2012032545A1 (en) 2010-09-08 2012-03-15 Cadila Healthcare Limited Processes for preparing dronedarone and its intermediates
EP2447256A1 (en) * 2010-10-21 2012-05-02 Laboratorios Lesvi, S.L. Process for obtaining dronedarone
CN102070579B (en) * 2011-01-19 2016-03-09 上海医药工业研究院 The preparation method of 2-normal-butyl-3-(4-replaces propoxy-benzoyl)-5-substituted-amino cumarone
CN102070581B (en) * 2011-01-19 2015-11-25 上海医药工业研究院 The preparation of 2-normal-butyl-3-(4-(the amino propoxy-of 3-di-n-butyl) benzoyl)-5-aminobenzofur
CN102070580B (en) * 2011-01-19 2015-05-20 上海医药工业研究院 Preparation of 2-n-butyl-3-(4-(3-di-n-butyl amino propoxyl) benzoyl)-5-substituted amino benzfuran
CN102070578B (en) * 2011-01-19 2015-10-14 上海医药工业研究院 The preparation method of 2-normal-butyl-3-(4-(the amino propoxy-of 3-di-n-butyl) benzoyl)-5-oxoethyl
WO2012120544A2 (en) 2011-03-10 2012-09-13 Sun Pharmaceutical Industries Ltd. PROCESS FOR N-[2-n-BUTYL-3-[4-[3-(DI-n-BUTYLAMINO) PROPOXY]ENZOYL]BENZOFURAN-5-YL]METHANESULFONAMIDE HYDROCHLORIDE
CN102690249B (en) * 2011-03-22 2014-09-17 江苏康缘药业股份有限公司 Preparation method of dronedarone
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
HUP1100166A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Reductive amination process for preparation of dronedarone using amine intermediary compound
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
WO2013014480A1 (en) 2011-07-26 2013-01-31 Sanofi Process for preparation of dronedarone using amide intermediary compound
WO2013014478A1 (en) 2011-07-26 2013-01-31 Sanofi Reductive amination process for preparation of dronedarone using carboxyl intermediary compound
WO2013014479A1 (en) 2011-07-26 2013-01-31 Sanofi Reductive animation process for preparation of dronedarone using aldehyde intermediary compound
ITMI20111672A1 (en) * 2011-09-16 2013-03-17 Olon Spa EFFICIENT METHOD FOR THE PREPARATION OF DRONEDARONE CHLORIDRATO
FR2983198B1 (en) * 2011-11-29 2013-11-15 Sanofi Sa PROCESS FOR THE PREPARATION OF 5-AMINO-BENZOYL-BENZOFURAN DERIVATIVES
EP2617718A1 (en) 2012-01-20 2013-07-24 Sanofi Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
WO2013121235A2 (en) 2012-02-13 2013-08-22 Sanofi Process for preparation of dronedarone by removal of hydroxyl group
WO2013121234A1 (en) 2012-02-14 2013-08-22 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
US9382223B2 (en) 2012-02-22 2016-07-05 Sanofi Process for preparation of dronedarone by oxidation of a hydroxyl group
US9238636B2 (en) 2012-05-31 2016-01-19 Sanofi Process for preparation of dronedarone by Grignard reaction
CN102675267B (en) * 2012-06-07 2015-05-13 济南富创医药科技有限公司 Preparation method of dronedarone hydrochloride and intermediate of dronedarone hydrochloride
CN108164411B (en) * 2017-12-29 2021-03-02 苏州汶颢微流控技术股份有限公司 Method for preparing p-heptyloxybenzoic acid based on microreactor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024273A (en) * 1974-06-20 1977-05-17 Smithkline Corporation Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity
US3947470A (en) * 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
FR2665444B1 (en) * 1990-08-06 1992-11-27 Sanofi Sa AMINO-BENZOFURAN, BENZOTHIOPHENE OR INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE COMPOSITIONS CONTAINING THEM.
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
US5631369A (en) * 1994-08-31 1997-05-20 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
CN1295200C (en) 2007-01-17
SK7272003A3 (en) 2003-11-04
FR2817865A1 (en) 2002-06-14
SK287770B6 (en) 2011-09-05
JP4437004B2 (en) 2010-03-24
CN100371314C (en) 2008-02-27
DE60124587T2 (en) 2007-09-20
CN1479706A (en) 2004-03-03
CA2429268A1 (en) 2002-06-20
JP2009024007A (en) 2009-02-05
CZ20031611A3 (en) 2003-08-13
DE60124587D1 (en) 2006-12-28
HK1055944A1 (en) 2004-01-30
US6846936B2 (en) 2005-01-25
HUP0500981A2 (en) 2006-03-28
ES2276741T3 (en) 2007-07-01
PL364774A1 (en) 2004-12-13
BR0116065A (en) 2003-10-28
CA2429268C (en) 2011-02-01
PL206029B1 (en) 2010-06-30
ATE345319T1 (en) 2006-12-15
DK1351907T3 (en) 2007-03-26
EP1351907B1 (en) 2006-11-15
HUP0500981A3 (en) 2012-09-28
BR0116065B1 (en) 2014-03-25
MXPA03005223A (en) 2004-04-20
EP1351907A1 (en) 2003-10-15
JP2004515536A (en) 2004-05-27
US20040010032A1 (en) 2004-01-15
FR2817865B1 (en) 2005-02-18
HRP20030471B1 (en) 2011-07-31
WO2002048078A1 (en) 2002-06-20
HRP20030471A2 (en) 2004-08-31
AR035663A1 (en) 2004-06-23
CZ303489B6 (en) 2012-10-17
CN1769262A (en) 2006-05-10

Similar Documents

Publication Publication Date Title
AU2002217227A1 (en) 2-butyl-3-(4-(3(dibutylamino)propoxy)benzoyl)-5-nitro- benzofuran hydrochloride and preparation thereof
AU2001270057A1 (en) Acoustical and thermal insulator
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2705201A (en) Ceramic structure
SI1252144T1 (en) Substituted glutarimides and use thereof il-12 production inhibitors
HK1064601A1 (en) Pharmaceutical compositions comprising amlodipene maleate
GB0104705D0 (en) Insulator ceramic composition
NO20006460L (en) 4, 5, 6 and 7-Indole and indoline derivatives, their preparation and use
HK1054031B (en) Pharmaceutically active pyrrolidine derivatives
AU5203601A (en) Platen construction and swing chair
HK1091806A1 (en) Antihistaminic piperidine derivatives and intermediates for the preparation thereof
SG100745A1 (en) Ceramic composition and ceramic capacitor
HUP0300399A3 (en) Herbicidal 3-(4,5-dihydroisoxazole-5-yl)benzoylpyrazoles, preparation and use thereof
AU3022201A (en) Novel use of (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)- chromane and its physiologically aceptable salts
HUP0103651A3 (en) Paroxetine maleate and process for its preparation
AU2001234180A1 (en) Benzamide derivative and use thereof
AU7053000A (en) Flint compounds and formulations thereof
PL353243A1 (en) An improved form of form i celiprolol hydrochloride
AU2001280460A1 (en) Pulmonary administration of flint
AU4304700A (en) Immunostimulatory pharmaceutical composition and its use protocol
AU2001241928A1 (en) Transferase 32253 and use therefor
AU2001286888A1 (en) Tyrosine hydroxylase 5' control elements and uses thereof
HK1045506B (en) Oxathiepino 6,5- i b /i ]dihydropyridines, and related compositions and methods
AU2002352774A1 (en) 55053, a novel human eukaryotic kinase and uses therefor
AU2002224105A1 (en) Piperidine compounds and medicinal use thereof